Abiopharma

(90% Positive) PROMIS NEUROSCIENCES INC. (PMN) Reports Q2 2026 Financial Results

New Form SCHEDULE 13G - AGREE REALTY CORP <b>Filed:</b> 2026-05-12 <b>AccNo:</b> 0000093751-26-000199 <b>Size:</b> 8 KB

New Form 424B2 - BANK OF AMERICA CORP /DE/ <b>Filed:</b> 2026-05-12 <b>AccNo:</b> 0001918704-26-012697 <b>Size:</b> 640 KB

Merck Highlights New Long-Term Data and Advancements Across Broad Oncology Portfolio and Pipeline Research at ASCO 2026

Jacobs awarded EPCM contract to deliver second Hut 8 AI data center in Texas

Genco Trading & Shipping Limited Sets the Record Straight on Diana’s False and Misleading Claims

Lazard Reports April 2026 Assets Under Management

MasTec to Host Investor Day in New York City Today at 8:45 AM ET

General Announcement: Minutes of Annual General Meeting held on 28 April 2026

New Form SCHEDULE 13G - AAR CORP <b>Filed:</b> 2026-05-12 <b>AccNo:</b> 0000093751-26-000198 <b>Size:</b> 8 KB

A motion for a derivative claim against the company and officers on the grounds of exploitation of a business opportunity at the time of purchasing a real estate asset

New Form SCHEDULE 13G - 4D Molecular Therapeutics, Inc. <b>Filed:</b> 2026-05-12 <b>AccNo:</b> 0000093751-26-000197 <b>Size:</b> 8 KB

Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s): Becoming a Substantial Shareholder

New Form 424B2 - BANK OF AMERICA CORP /DE/ <b>Filed:</b> 2026-05-12 <b>AccNo:</b> 0001918704-26-012696 <b>Size:</b> 1 MB

New Form 424B2 - JPMORGAN CHASE & CO <b>Filed:</b> 2026-05-12 <b>AccNo:</b> 0001213900-26-054799 <b>Size:</b> 301 KB